Procaps Group, S.A Price to Free Cash Flow Ratio 2020-2023 | PROCF

Historical price to free cash flow ratio values for Procaps Group, S.A (PROCF) since 2020. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Procaps Group, S.A Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2025-02-03 1.01 2.16
2023-09-30 3.62 $0.47 7.74
2023-03-31 4.51 $-0.08 0.00
2022-12-31 5.25 $-0.04 0.00
2022-09-30 7.00 $-0.07 0.00
2022-06-30 9.32 $0.17 55.94
2022-03-31 8.50 $0.17 49.25
2021-12-31 9.75 $0.16 60.22
2021-09-30 10.20 $0.41 24.75
2023-06-30 4.30 $-1.31 0.00
2021-06-30 10.09 $-1.22 0.00
2021-03-31 10.05 $-1.27 0.00
2020-12-31 10.40 $-1.47 0.00
2020-09-30 9.93 $-0.07 0.00
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.125B $0.410B
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
Stock Name Country Market Cap PE Ratio
NextEra Energy Partners, LP (XIFR) United States $0.828B 4.49